WEST PHARMACEUTICAL SERVICES, INC. Share Repurchase Authorization
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Share Repurchase Authorization of $1.00 billion as of 2023-02-28, per its 10-Q filed 2023-04-27.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2023-04-27
- 2023-02-28: Stock Repurchase Program, Authorized Amount $1.00B.
- 2014-12-31: Stock Repurchase Program, Authorized Amount $100.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2023-02-28 | $1.00B 10-Q · filed 2023-04-27 |
| 2014-12-31 | $100.00M 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |